On April 1, 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Tylenol lawsuits into one court in the Eastern District of Pennsylvania. The panel ruled that all cases shared common matters of fact, and that handling them together would be more…
In 2013, a study published in JAMA Internal Medicine reported that prescriptions for testosterone therapy products increased threefold between 2001 and 2011. Among all new users of the drugs, more than a quarter had not had their testosterone levels checked before starting the treatment. Recent…
A new report recently released by the Acetaminophen Awareness Coalition (AAC) seeks to increase awareness of the potential dangers of taking too much acetaminophen (Tylenol). An acetaminophen overdose remains the leading cause of acute liver failure in the U.S. In January 2014, the FDA released…
One of the most common potential side effects of the anti-psychotic Risperdal (risperidone) is weight gain. According to a report by CNN, dramatic weight gain occurs in as many as 30 percent of patients who take drugs like Risperdal. The medications can also increase risk…
Now that all federal testosterone lawsuits have been consolidated in the Northern District of Illinois, lawmakers are seeking coordination between state courts and the new MDL. Testosterone replacement therapy manufacturers AbbVie and Abbott Laboratories (AndroGel) requested the federal court discus
On June 6, 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all federal lawsuits concerning testosterone replacement products (like AndroGel and Testim) be centralized into one court in the Northern District of Illinois. The panel determined that though some manufacturers hav
A Pennsylvania judge signed an order on June 10, 2014 denying a motion to dismiss a case against Johnson & Johnson involving the wrongful death of an infant (No. 12-4162). Stacy Sherfey and Neil Sherfey, of Nevada, filed a complaint in 2012 alleging that their…
Another Risperdal lawsuit has been filed due to serious side effects. Andrew Wasserman and his mother, Mary Wasserman, filed the complaint on June 12, 2014 against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals (3:14-cv-02739). Andrew allegedly developed breasts requiring a double mas
Manufacturers of testosterone therapy products will now include a more general warning on their labels about the risk of blood clots in the veins tied to the use of these drugs. Drug labels on approved testosterone therapy products already warned about the risk of “venous…
A study published in The Journal of the American Medical Association (JAMA) of Internal Medicine analyzed data from 25,848 men and found that Sildenafil citrate, the ingredient in Viagra, manufactured by Pfizer, increased the risk of developing melanoma. The study found that the drug apparently…
After a January FDA warning about possible safety risks with testosterone replacement therapy, many men have filed testosterone lawsuits against manufacturers of drugs like AndroGel, Testim, Depo-Testosterone, and more. Recently, plaintiffs filed a new case (1:14-cv-02495) in the U.S. District Court
All lawsuits involving testosterone therapy treatments have been consolidated before one federal judge, the Honorable Matthew F. Kennelly, in the Northern District of Illinois. The Multidistrict (“MDL”) consolidation order was issued on June 6, 2014 and impacts “45 actions pending in four districts”